Bio-Rad Laboratories | BIO - Debt

Stock Price
278.89
Daily Change
-1.10 -0.39%
Monthly
2.74%
Yearly
26.57%
Q2 Forecast
271.56

Bio-Rad Laboratories reported $1.4B in Debt for its fiscal quarter ending in September of 2025.





Debt Change Date
Abbott USD 12.94B 496M Sep/2025
Agilent USD 3.35B 55M Sep/2025
Becton, Dickinson and Co. USD 19.54B 358M Dec/2025
Bio Techne USD 260M 40M Dec/2025
Bio-Rad Laboratories USD 1.4B 11.2M Sep/2025
Bruker USD 2.01B 426.8M Sep/2025
Charles River Laboratories USD 2.63B 157.4M Sep/2025
Danaher USD 18.42B 1.56B Dec/2025
General Electric Aerospace USD 20.49B 344M Dec/2025
Hologic USD 2.63B 104.3M Sep/2025
Illumina USD 2.58B 22M Sep/2025
IQVIA Holdings USD 15.72B 767M Dec/2025
Laboratory Of America USD 6.53B 16.1M Sep/2025
Merck USD 41.37B 5.97B Sep/2025
Mettler Toledo International USD 2.21B 25.94M Sep/2025
Myriad Genetics USD 59.3M 19.7M Mar/2025
OraSure Technologies USD 782K 465K Jun/2024
Pacific Biosciences Of California USD 892.24M 653K Dec/2023
Quest Diagnostics USD 6.38B 2M Sep/2025
Repligen USD 542.21M 146.65M Dec/2025
Revvity USD 3.37B 5.86M Sep/2025
Roche Holding CHF 33.03B 1.41B Jun/2025
Siemens EUR 56.02B 673M Sep/2025
Standard Biotools USD 27.39M 1.23M Sep/2025
Thermo Fisher Scientific USD 35.68B 451M Sep/2025
Tosoh JPY 172.31B 6.79B Sep/2025
Waters USD 1.49B 52.2M Sep/2025